MaxioCel

We are delighted to announce our presence with MaxioCel CE Certified and US FDA cleared at the 6th Global Wound Conference 2024 from 18th to 20th October 2024. Maxiocel with its novel BMG technology using 100% Chitosan is designed to manage exudates while providing the robust anti-microbial barrier and granulation through its versatile properties. To know more, join us at Booth No. 33, at the Sunway Pyramid Convention Centre, Malaysia. Discover innovations that are setting new standards in wound management. Schedule a meeting here: https://lnkd.in/dXxJMqqj #MaxioCel #GWC2024 #WoundCareInnovation #BMGTechnology #RevolutionizingHealing #Chitosan #woundmanagment

Milestone achieved! We are thrilled to announce that our MaxioCel Chitosan Wound Dressing has been granted an Indian patent! This marks a significant step forward in our mission to enhance wound care and improve healing outcomes globally. #MaxioCel #Chitosan #WoundCare #AxioBiosolutions #Innovation #BMG

Transforming Chronic Pilonidal Sinus Care with Proven Results! A persistent non-healing pilonidal sinus, as documented by Paula Smith, Tissue Viability Nurse, Care Plus Group, North East Lincolnshire (EWMA 2024), saw significant progress with MaxioCel: Treatment with MaxioCel: Goals: Promote autolytic debridement, manage exudate, and facilitate the path to recovery. Outcome: First noticeable improvement in 5 years. Reduction in nursing appointments. Decreased antibiotic dependency. Elimination of further hospital admissions. Clinicians observed: "A remarkable difference after switching to MaxioCel. The wound began healing for the first time in years." For detailed insights, visit our study: https://lnkd.in/d_qEkgb5 Discover more: www.maxiocel.com #WoundCare #HealthcareInnovation #MaxioCel #PatientRecovery

Transforming Pressure Ulcer Care with Proven Healing Results! A 62-year-old female with a Category 4 sacral pressure ulcer, as detailed in Chronic Wound Debridement in an Acute Setting (EWMA 2024), experienced remarkable improvements with MaxioCel: Treatment with MaxioCel: Goals: Autolytic debridement, exudate management, healing promotion Day 7: Slough reduced to 30%, granulation increased to 70%, pain reduced from 9 to 7 Day 14: Stable wound with 30% slough, 70% granulation, and healthy peri-wound skin Clinicians noted: “Big difference when changing from silver dressing. After 1 week, reduced sloughy tissue. Appears healthier.” Discover more: www.maxiocel.com #WoundCare #HealthcareInnovation #MaxioCel #PatientRecovery

Axio Biosolutions has successfully implemented environmental sustainability principles across its value chain, connecting nature with life-saving innovation. Our eco-friendly process minimizes energy use to make haemostats and wound care products from shellfish shells, significantly reducing the overall carbon footprint. We utilize ~10.5 metric tons of shellfish shells annually, preventing their disposal. Last year, Axio acquired 34,810+ units of Secondary Folding Box Board (FBB), cutting plastic use by 450 kg, and procured ~7,525 kg of corrugated boxes using 100% recycled packaging materials, saving nearly 128 trees annually. This commitment enables sustainable operation and a healthier planet for future generations. #EcoFriendly #GreenInnovation #AxioBiosolutions #worldenvironmentday

Dive into 'Bioactive Microfibre Gelling (BMG™) Technology to Support Patient Self Care' by Paula Smith, Tissue Viability Nurse at Care Plus Group North East Lincolnshire. Discover the secrets behind rapid wound healing, efficient exudate management, and enhanced quality of life.  Read the full article at: https://lnkd.in/d_qEkgb5. For further inquiries, contact us at info@axiobio.com. Presented at EWMA Conference 2024, London. #Healthcare #WoundCare #PatientSelfCare #EWMA2024

Chronic Wound Debridement in an Acute Setting: Unlocking Improved Management Objectives with Bioactive Microfibre Gelling (BMG™) Technology" by Danielle Blake of Barking, Havering and Redbridge University Hospitals NHS Trust, UK. Presented at EWMA 2024, delve into Danielle Blake's comprehensive analysis shedding light on chronic wound debridement in an acute setting. Uncover the transformative potential of Bioactive Microfibre Gelling (BMG™) technology in enhancing wound management objectives. Click the link here: https://lnkd.in/d_qEkgb5 to explore the forefront of wound care innovation! #Maxiocel #WoundCare #Innovation #EWMA2024 #BioactiveTechnology #ChronicWounds #AcuteCare #MedicalResearch #HealthcareAdvancements #BMGTechnology #WoundManagement

Severe Pressure Ulcer Debridement in the Acute Sector: Our Latest Breakthrough with Bioactive Microfiber Gelling Dressings, MaxioCel. Explore our latest article, authored by Eva Di Romana and presented at EWMA 2024, revealing the swift efficacy of our innovative approach to wound care. Discover how our BMG™ dressings effectively address pain, reduce bioburden, and promote granulation, all while maintaining cost-effectiveness. Read the full article now: https://lnkd.in/d_qEkgb5 #PressureUlcerCare #WoundManagement #HealthcareInnovation #EWMA2024 #PatientOutcomes #BMGDressing #CostEffectiveCare #WoundCare #Healthcare

Reflecting on the enriching experience at #EWMA2024, we extend a warm thank you to our esteemed partners and visitors. Your participation in exploring the MaxioCel on wound healing and the insightful discussions regarding the Bioactive Microfiber Gelling (BMG) Technology were truly appreciated. For further information or inquiries, please do not hesitate to contact us at info@axiobio.com. Thank you once again for your time and interest. We look forward to the possibility of collaborating with you in the future. #EWMA2024 #MaxioCel #BMGTechnology #Axiobiosolutions

Good morning, London! Join us today at European Wound Management Association #EWMA2024 as we showcase our wound care product. Axio Biosolutions proudly introduces MaxioCel, in collaboration with CD Medical Ltd! Designed to expedite healing and elevate patient comfort, MaxioCel combines Bioactive Microfiber Gelling (BMG) technology with 100% Chitosan, ensuring superior outcomes and enhanced quality of life for patients globally. Visit our booth at F74 and let's redefine healthcare together with innovative solutions. #EWMA2024 #WoundCare #HealthcareInnovation #MaxioCel #AxioBiosolutions #CDMedical #BioactiveTechnology #Chitosan #PatientCare #MedicalAdvancements